The specific drug names can be found in Supplemental Table 3
Using data from the All of Us Research Program (n=18,746), we conducted both intention-to-treat and per-protocol phenome-wide association studies comparing diagnoses following GLP-1 RA prescription, including semaglutide-specific analyses, to those following sodium-glucose cotransporter-2 inhibitor (SGLT2i) and dipeptidyl peptidase-4 inhibitors (DPP4i) prescriptions in individuals with T2D
Weight loss clinics, in particular, must navigate the complexities of the International Classification of Diseases, Tenth Revision (ICD-10), to document diagnoses and procedures accurately
As larger pharmaceutical companies seek to expand their portfolios and leverage new technologies, they may acquire smaller companies working on new drugs
Mounjaro is the diabetes-approved version of tirzepatide
If the difference between the two values was more than 0.5%, we considered the subject to have responded to the treatment (score of 1)
